Latest news with #GS-441524
Yahoo
6 days ago
- Business
- Yahoo
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J., June 05, 2025--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. "FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too," said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. "For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance." "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients," said Nicole Jacque, co-founder of FIP Global Cats. "Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP." Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About WedgewoodWedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit View source version on Contacts Jennifer Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
6 days ago
- Business
- Business Wire
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment." Share GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. 'FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too,' said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. 'For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance.' "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients,' said Nicole Jacque, co-founder of FIP Global Cats. 'Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP.' Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About Wedgewood Wedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit
Yahoo
31-01-2025
- Yahoo
Cedar Park woman sentenced for multi-million-dollar scheme that defrauded cat owners
The Brief A Cedar Park woman pleaded guilty to a federal charge and was sentenced to 1 year probation The woman carried out a multi-million-dollar scheme that defrauded cat owners nationwide over several years A person who knew the woman spoke out CEDAR PARK, Texas - A Cedar Park woman pleaded guilty to a federal charge and was sentenced on Monday. She must serve one year of probation and forfeit roughly $4 million in assets. The multi-million-dollar scheme defrauded cat owners nationwide over several years. Nicole Randall, 37, of Cedar Park carried out the online operation. The backstory The person FOX 7 Austin spoke with asked to stay anonymous, but they knew Randall through volunteering at Austin Pets Alive!. "Nicole Randall was my friend. To understand who she is, how she got involved with the black market FIP, and what happened, you have to understand her story. I met Nicole in 2018. She was looking to adopt. She found the perfect kitten, whose name was Baconator. She took him home, and after two months, he got sick." The source said a veterinarian diagnosed the new kitten with Feline Infectious Peritonitis (FIP). It is a deadly disease in cats that has long been considered incurable. "Nicole went to the Internet, and she came across a drug called GS-441524." GS can be used to treat the deadly disease, but it was not legal in the United States at the time. Within a few weeks, Baconator died from FIP. "Nicole and several others started the group FIP Warriors, a group of pet owners who were sourcing GS through the Chinese black market." The Facebook group currently has 82.9K members, including a former Austinite, who has had two cats diagnosed with the disease. "Admins of the FIP Warriors group sought to figure out which products being offered in this space were actually safe and effective." The page is a space that people turn to in a time of desperation. They are cat owners seeking answers, support, and a lifeline for their dying animal. "Nicole saw an opportunity to make money because pet owners will spend thousands of dollars to save the life of their cat." Randall used fake names on the Chinese black market to purchase and smuggle illegal medication into the country, disguising it as pet shampoo, cosmetics, face masks, and other beauty products. She collected the money through various mobile payment apps, including Venmo, CashApp, and PayPal. "We were shocked to learn how high the profits were. Especially because so many families would refinance their houses or even sell their plasma to afford treatment." The backstory An undercover investigation was launched in the summer of 2021. A year later, agents executed a search warrant at her Cedar Park home, where they found around 30 boxes containing the illegal drug. According to the DOJ, they believe she distributed 58,460 liquid vials and 236,836 pills of GS-441524 over two years. Click to open this PDF in a new window. "We did not learn how much Nicole made until the raid." As part of the plea deal Randall took, she had to give up four properties, a Tesla, and 10 financial accounts totaling roughly $4 million. Randall was charged with criminal information with introducing an adulterated drug into interstate commerce. What they're saying As for the legality of GS, it has since changed. "Treatment is more accessible, it's more affordable, it's safer. And veterinarians can actually be the ones in the driver's seat prescribing and treating their patients." Technically, the treatment option is still not legally available in the U.S. However, a veterinarian can now prescribe and compound it in certain circumstances. The Source Information from interviews conducted by FOX 7 Austin's Katie Pratt
